Navigation Links
Par Pharmaceutical Reports Second Quarter 2008 Results
Date:8/7/2008

/p>

Revenues:

Net product sales $108,289 $160,014 $259,526 $382,603

Other product related

revenues 4,648 7,626 8,339 19,247

Total revenues 112,937 167,640 267,865 401,850

Cost of goods sold 87,829 111,085 193,236 257,606

Gross margin 25,108 56,555 74,629 144,244

Operating expenses:

Research and development 15,955 14,277 33,113 28,316

Selling, general and

administrative 36,690 33,999 68,037 66,556

Settlements, net - - - (578)

Total operating expenses 52,645 48,276 101,150 94,294

Gain on sale of product

rights and other (500) - (2,125) (20,000)

Operating (loss) income (27,037) 8,279 (24,396) 69,950

Other (expense) income, net - (30) - (49)

Equity in loss of joint

venture (310) (80) (330) (228)

Loss on marketable

securities and other

investments, net (433) (6,040) (433) (4,643)

Interest income 2,129 3,901 5,143 6,585

Interest expense (1,667) (1,727) (3,334) (3,445)

(Loss) income from

continuing operations

before provision for

income taxes (27,318) 4,303 (23,350) 68,170

(Benefit) provision for

income taxes (7,523) 1,505 (6,081) 23,858

(Loss) income from

continuing operations (19,795) 2,798 (17,269) 44,312

Discontinued operations:

Gain from discontinued

operations - -
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. Memory Pharmaceuticals to Announce Second Quarter 2008 Results on Wednesday, August 13, 2008
3. Watson Pharmaceuticals Reports Second Quarter 2008 Results
4. XTELL Launches its Commercial Biorepository Services for Research and Pharmaceutical Companies
5. Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
6. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
7. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
8. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
10. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
11. Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... (PRWEB) January 23, 2015 Biofertilizers stimulate ... such as nitrogen and phosphorous through the activities in ... biofertilizers is increasing due to the stress on reducing ... fertilizers. , The report defines and segments the bio ...
(Date:1/22/2015)... January 22, 2015 Shimadzu Scientific ... UV-1280 multipurpose UV-visible spectrophotometer. Offering wavelength scanning from ... is ideal for applications in a variety of ... , The user-friendly UV-1280 enables intuitive operation, while ...
(Date:1/22/2015)... CAMBRIDGE, Mass (PRWEB) January 21, 2015 Cambridge ... Semantic Web technology, today announced that 2014 was a record-breaking ... expanding the capabilities of the Anzo Smart Data Platform and ... discover and utilize insights from diverse data which led to ...
(Date:1/22/2015)... California (PRWEB) January 22, 2015 Pipette.com ... Offer to their comprehensive portfolio of Eppendorf products. ... customers to purchase a Centrifuge 5424/5424 R and receive ... of either Eppendorf Research plus or Eppendorf Reference 2 ...
Breaking Biology Technology:Biofertilizers Market Expected to Reach $1,649.7 Million by 2019 - New Report By MarketsandMarkets 2Biofertilizers Market Expected to Reach $1,649.7 Million by 2019 - New Report By MarketsandMarkets 3Biofertilizers Market Expected to Reach $1,649.7 Million by 2019 - New Report By MarketsandMarkets 4Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Cambridge Semantics Announces Record Results for 2014 2Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2
... ANNAPOLIS, Md., April 2, 2008 ... company specializing in the development and,commercialization of ... today that it has completed its acquisition ... March 20,2008., David P. Wright, President ...
... April 2, 2008 In,testimony to be delivered today ... for Taxpayer and Consumer,Rights) backed a bill in the ... The bill, SB 1565, was introduced by Sen. ... to ensure California,s neediest residents,will have access to therapies ...
... 2, 2008 Joseph F. Finn,Jr., CPA, the Assignee ... completion of the sale of ActivBiotics intellectual,property assets for ... II antibiotic, 2) a library of novel rifamycin compounds, ... a library of SODm,small molecules., Mr. Finn praised ...
Cached Biology Technology:PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit 2PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit 3PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit 4PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit 5Consumer Advocate Testifies in Support of Stem Cell Oversight Legislation 2
(Date:1/22/2015)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a biometric ... recent success of the Wocket™ smart wallet at CES 2015 in ... named as one of the "11 Hot Products at CES" in a ... CES So Far" by Newseveryday.com and "The top 10 gadgets from CES ...
(Date:1/22/2015)... Jan. 21, 2015  Analyst Report Issued by Small Cap IR. ... showed that planet-wide, transactions at merchants on the leading payment ... number of credit, debit, and prepaid cards reached 6.54 billion.  ... of fraudulent card usage in 2012, and credit and debit ...
(Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ... "Global Wearable Technologies Market and Applications, Opportunities, Industry ... Forecast 2014-2020" report to their offering. ... that can be worn on the user,s body ...
Breaking Biology News(10 mins):CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... 18, 2010 Reportlinker.com announces that a new market ... Global Flow Cytometers Industry ... markets for Flow Cytometers in US$ Million. The report ... Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts ...
... 2010) Discovery of a fifth gene defect and the ... are the subject of studies released this month involving researchers ... (UTHealth). In both studies, the investigators have identified alterations ... of smooth muscle cells, which line the aorta and other ...
... is Back and Oberthur Technologies Remains a Key Partner -- CHANTILLY, Virginia, November 18, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, ...
Cached Biology News:Reportlinker Adds Global Flow Cytometers Industry 2Reportlinker Adds Global Flow Cytometers Industry 3Reportlinker Adds Global Flow Cytometers Industry 4Reportlinker Adds Global Flow Cytometers Industry 5Reportlinker Adds Global Flow Cytometers Industry 6Reportlinker Adds Global Flow Cytometers Industry 7Reportlinker Adds Global Flow Cytometers Industry 8Reportlinker Adds Global Flow Cytometers Industry 9UTHealth discoveries shed more light on deadly thoracic aortic disease 2UTHealth discoveries shed more light on deadly thoracic aortic disease 3The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 2The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 3The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 4The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 5The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 6The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 7The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 8The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 9
... The DNA quantitation kit is used to ... the presence of RNA or protein. With this ... which can be detected with a VersaFluor or ... range of 10 ng per ml to 5 ...
ImmunoPure Plus Immobilized Protein G, , , , Support: Cross-linked 6%, beaded agarose , Capacity: > 20 mg human IgG/ml of gel ...
... Infinite 200 series of microplate readers combines ... detection in an affordable, easy-to-use platform for ... The unique modular design and adaptability of ... a choice of a monochromator (M200) or ...
...
Biology Products: